About Denosumab
            
            Class: | Monoclonal antibody (RANKL inhibitor)  
Use: | Treatment of osteoporosis in postmenopausal women at high risk for fracture, treatment of osteoporosis in men at high risk for fracture, prevention of skeletal-related events in patients with bone metastases from solid tumors, and treatment of giant cell tumor of bone.  
Adult dose: | 60 mg subcutaneously once every 6 months for osteoporosis; 120 mg subcutaneously once every month for bone metastases; 120 mg subcutaneously once every 4 week
         
        
            
                
                
                    
                        Drug Class
                    
                    Monoclonal antibody (RANKL inhibitor)
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of osteoporosis in postmenopausal women at high risk for fracture, treatment of osteoporosis in men at high risk for fracture, prevention of skeletal-related events in patients with bone metastases from solid tumors, and treatment of giant cell tumor of bone.
                 
                
                
                    
                        Storage Requirements
                    
                    Store in the refrigerator at 2°C to 8°C (36°F to 46°F); do not freeze. Can be kept at room temperature (up to 25°C or 77°F) for up to 30 days prior to use.
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Amgen Europe B.V., NETHERLANDS
                    
                    
                    Package Size
                    1ml Pre-filled Syringe x 1
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 1702.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        60 mg subcutaneously once every 6 months for osteoporosis; 120 mg subcutaneously once every month for bone metastases; 120 mg subcutaneously once every 4 weeks for giant cell tumor of bone.
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients; not recommended for use in children.
                    
                 
                
                
                    
                        Side Effects
                    
                    Back pain, pain in extremity, hypercholesterolemia, hypocalcemia, musculoskeletal pain, and skin reactions at the injection site.
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypocalcemia, hypersensitivity to denosumab or any component of the formulation, and pregnancy (category X).
         
        
        
            
                Important Warnings
            
            Risk of serious infections, osteonecrosis of the jaw (ONJ), atypical femoral fractures, and hypocalcemia; patients should be assessed for hypocalcemia prior to initiation and monitored during treatment.
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.